Examines Doctor and Agency Hostility amid Growing Republican Support of Cannabis

Jan 08, 2015, 05:00 ET from DigiPath, Inc.

LOS ANGELES, Jan. 8, 2015 /PRNewswire/ -- The National Marijuana News Corp., a wholly owned subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its seventh unbiased cannabis news show. Hosted by Todd Denkin and Jen Gentile, the program explores how institutions are still fighting against the use of medical cannabis, while fiscally conservative Republicans embrace legalization.

"This segment of TNMNews underscores the need for increased levels of cannabis news and education to overcome widespread ignorance in the government and medical community," says TNMNews cohost Todd Denkin. "As Sierra Riddle points out in her interview, 48 children are diagnosed with cancer every day, and not all of them can tolerate chemotherapy. It's irresponsible to pretend there are no alternatives."

In her interview with TNMNews, the mother of a two-year-old leukemia patient Sierra Riddle describes her legal struggle with oncologists and Child Protective Services after choosing cannabis oil over chemotherapy treatments, which she felt were killing her son Landon. She recalls how after four weeks on cannabis therapy, he felt better and no longer required additional blood and platelet transfusions. However, even as Landon's leukemia went into remission, Sierra was reported to CPS several times for refusing to continue her son's chemotherapy, and she was forced to hire an attorney to fight mounting efforts to move her son to a foster family that would administer chemotherapy.

Next, Allison Margolin, known as "LA's Dopest Attorney," discusses problems with current and proposed Driving Under the Influence (DUI) laws, since today's standard drug tests show a positive indication 30 days after use. Margolin, who is the daughter of the director of the Los Angeles chapter of NORML (National Organization for the Reform of Marijuana Laws), Bruce Margolin, reviews the efforts to overturn federal marijuana laws on the grounds that there is a lack of a rational basis for keeping cannabis classified as a Schedule I drug. According to Margolin, the federal government is going to have a hard time justifying its opposition to reclassification after its leniency on the sale and use of marijuana in places like Colorado, where both the medicinal and recreational use of cannabis is now allowed by state law.

Margolin's interview is followed by a talk with the assistant executive director of Republicans Against Marijuana Prohibition (RAMP), Zoe Russell. She describes how Ann Lee founded RAMP after discovering that marijuana relieved her 28-year-old son's severe nerve pain, stemming from a workplace accident that also left him a paraplegic.

Finally, the show welcomes radio legend and comedian Jackie Martling as TNMN's East Coast correspondent. Martling explains what he plans to bring to the program in his new position, including guests he will interview, topics he plans to discuss and cannabis-related events he's scheduled to cover.

To book a guest or advertise on, please contact:

Martin Wagmaister
(310) 561.6179

About The National Marijuana News

The times are changing, and TNMNews works hard to deliver the news to help you make sense of it all. The medicinal use of marijuana is now legal in 23 States plus the District of Columbia, and recreational use is legal in four states—making cannabis a topic that increasingly demands unbiased examination. TNMNews brings together cannabis-industry and thought leaders to discuss and debate the scientific, medicinal, political, commercial, legal, spiritual, and cultural dimensions of cannabis in today's world.

For more information, go to

About DigiPath, Inc.

DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the cannabis industry. Our four business units are DigiPath Labs, TNM News Corp., DigiPath Corp., and DigiPath University.

For more information, go to

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

DigiPath, Inc.
Investor Relations
(888) 552-4440

Logo -


SOURCE DigiPath, Inc.